Insights On Partnering

  1. The Tax Reporting Threshold Just Went from $600 to $2K — What to Know 7/22/2025

    Explore the implications of the newly enacted "One Big Beautiful Bill" and how it will alleviate the administrative burdens faced by clinical research stakeholders and benefit low-income patients.

  2. When Should You Rescue Your Clinical Trial From A Bad RTSM? 4/28/2026

    Stop settling for tech delays that drain your team. Learn how to evaluate a mid-study transition and implement a rescue plan that restores efficiency and control to your clinical operations.

  3. Ensure The Safe And Efficient Development Of High Potent Drug Products 8/16/2025

    As your product transitions from clinical phases to commercial launch, flexible, globally compliant facilities stand ready to adapt to your evolving needs.

  4. Building Bioanalysis Infrastructure For Modern Drug Development 10/20/2025

    Drug development accelerates with AI, decentralized trials, and adaptive protocols, but legacy CRO infrastructure lags. Platform-based systems enable speed, quality, automation, and continuous improvement.

  5. Two Views Of Risk When Choosing An IRT/RTSM Software Partner 5/5/2026

    In this clip, Ryan Keane of Korio explains why legacy RTSM vendors, designed for large pharmaceutical companies, often struggle to serve smaller, fast-moving Sponsors.

  6. Medable's Japanese Clinical Trial Exceeds FPI Date And eCOA Adherence 3/10/2025

    A top-10 global pharma company aimed to address eCOA adherence and patient enrollment challenges faced by clinical trial sites in Japan. Explore an initiative to enhance the patient and site experience.

  7. Case Management Accelerates Shipment For SCN1A+ Dravet Syndrome Gene Therapy 3/12/2026

    Consider this streamlined, end-to-end solution that helped safeguard study timelines and ensured that patients with urgent medical needs could receive treatment without delay.

  8. Debunking 5 Misconceptions About Community-Based Research Sites 5/28/2025

    By confronting misconceptions about community-based research, we uncover evidence of how sites effectively manage complex trials while maintaining high standards of care.

  9. Accelerator™ Drug Development 360° CDMO And CRO Solutions 3/4/2026

    Review this coordinated suite of integrated solutions that brings together CDMO and CRO capabilities across clinical research, manufacturing, and clinical supply.

  10. PCI Capacity Update July 2025: Small Molecule Drug Product/Finished Dosage Form 7/29/2025

    Dr. Rebecca Coutts highlights PCI’s high potent oral solid dose (OSD) and oral liquid capabilities, focusing on site expertise, specialized infrastructure, and handling of complex molecules.